Recruiting
Study of Pembrolizumab Combined with Chemotherapy in the First Line Therapy for R/M HNSCC in China
NCT04857164
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
- Locations
-
- National Cancer Center/Cancer Hospitial,Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, Beijing Municipality, China